Patents by Inventor Raju Mohan

Raju Mohan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liver X receptor (LXR) modulators
    Patent number: 10246419
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: April 2, 2019
    Assignee: RALEXAR THERAPEUTICS, INC.
    Inventor: Raju Mohan
  • Fused bicyclic compounds for the treatment of disease
    Patent number: 10233187
    Abstract: A compound having the Formula (I), or a pharmaceutically acceptable salt or solvate thereof:
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: March 19, 2019
    Assignee: AKARNA THERAPEUTICS, LTD.
    Inventors: Benjamin Anthony Pratt, Raju Mohan
  • Fused bicyclic compounds for the treatment of disease
    Patent number: 10167294
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: January 1, 2019
    Assignee: Akarna Therapeutics, Ltd.
    Inventors: Raju Mohan, Benjamin Anthony Pratt
  • Liver X. Receptor (LXR) Modulators for the Treatment of Dermal Diseases, Disorders and Conditions
    Publication number: 20180370959
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: April 18, 2018
    Publication date: December 27, 2018
    Inventor: Raju Mohan
  • LIVER X RECEPTOR (LXR) MODULATORS
    Publication number: 20180346427
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: August 3, 2018
    Publication date: December 6, 2018
    Inventor: Raju MOHAN
  • FUSED BICYCLIC COMPOUNDS
    Publication number: 20180346473
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their preparation.
    Type: Application
    Filed: May 31, 2018
    Publication date: December 6, 2018
    Applicant: Akarna Therapeutics, Ltd.
    Inventors: Raju MOHAN, Benjamin Anthony PRATT
  • Liver X receptor (LXR) modulators
    Patent number: 10047055
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: August 14, 2018
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan
  • Liver X receptor (LXR) modulators
    Patent number: 9981913
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: May 29, 2018
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20180118752
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: September 25, 2017
    Publication date: May 3, 2018
    Inventors: Raju MOHAN, Benjamin Anthony PRATT
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20170355704
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: June 22, 2017
    Publication date: December 14, 2017
    Inventors: Raju MOHAN, Benjamin Anthony PRATT
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20170355699
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: May 19, 2017
    Publication date: December 14, 2017
    Inventors: Benjamin Anthony PRATT, Raju MOHAN
  • LXR modulators
    Patent number: 9834542
    Abstract: The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXR), compositions comprising any of such novel compounds, methods of using these compounds or compositions as medicaments for prevention or treatment of diseases or disorders related to liver X receptor (LXR), as well as methods of preparing these LXR modulators and using them in the manufacture of medicaments.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 5, 2017
    Assignees: Bristo-Myers Squibb Company, Exelixis Patent Company LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Meriah Valente, Nicholas Wurtz, Sharanabasappa Patil
  • Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions
    Publication number: 20170334897
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of milizing LXR modulators in the treatment of dermal diseasess, disorders or conditions. Also described herein are pharmaceutical compositions containg such compounds.
    Type: Application
    Filed: April 3, 2017
    Publication date: November 23, 2017
    Inventor: Raju Mohan
  • LXR modulators
    Patent number: 9751869
    Abstract: The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 5, 2017
    Assignees: Bristol-Myers Squibb Company, Exelixis Patent Company LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Brett B. Busch, Claudia Averbuj, Meriah Valente, Nicholas Wurtz, Prasanna Savanor Maddu Rao, Jeevanprakash Shetty, Alla Venu
  • Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions
    Patent number: 9637481
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: May 2, 2017
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan
  • LXR MODULATORS
    Publication number: 20160304499
    Abstract: The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXR), compositions comprising any of such novel compounds, methods of using these compounds or compositions as medicaments for prevention or treatment of diseases or disorders related to liver X receptor (LXR), as well as methods of preparing these LXR modulators and using them in the manufacture of medicaments.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 20, 2016
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, EXELIXIS PATENT COMPANY LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Meriah Valente, Nicholas Wurtz, Sharanabasappa Patil
  • LXR MODULATORS
    Publication number: 20160289222
    Abstract: The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 6, 2016
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, EXELIXIS PATENT COMPANY LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Brett B. Busch, Claudia Averbuj, Meriah Valente, Nicholas Wurtz, Prasanna Savanor Maddu Rao, Jeevanprakash Shetty, Alla Venu
  • Liver X Receptor (LXR) Modulators
    Publication number: 20160221956
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: September 4, 2014
    Publication date: August 4, 2016
    Applicant: ALEXAR THERAPEUTICS, INC.
    Inventor: Raju Mohan
  • Liver X Receptor (LXR) Modulators
    Publication number: 20160214943
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 28, 2016
    Inventor: Raju Mohan
  • LXR MODULATORS
    Publication number: 20150299136
    Abstract: Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Application
    Filed: May 4, 2015
    Publication date: October 22, 2015
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, EXELIXIS PATENT COMPANY LLC
    Inventors: Brett B. Busch, William C. Stevens, JR., Ellen K. Kick, Haiying Zhang, Venkataiah Bollu, Richard Martin, Raju Mohan